Literature DB >> 16261717

[The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].

J C de Jong1, G F Rimmelzwaan, A I M Bartelds, A Meijer, R A M Fouchier, A D M E Osterhaus.   

Abstract

In the Netherlands, the influenza epidemic of the 2004/'05 season started late. The background value of 3 cases of an influenza-like illness per 10,000 inhabitants per week was exceeded from week 1 until week 14 of 2005. The magnitude of the epidemic was the largest of the last 5 years, namely 104 per 10,000 inhabitants. As usual, the epidemic was caused mainly by influenza-A viruses of subtype H3N2 and to a lesser degree by A/H1N1 and B viruses. The H3N2-virus isolates belonged to the newly emerged variant A/California/7/04, which deviated slightly from the vaccine strain used for the 2004/'05 season. The influenza-B and H1N1 viruses matched the corresponding vaccine viruses well. For the 2005/'06 season, the World Health Organization has recommended the following vaccine composition: A/California/7/04 (H3N2), A/New Caledonia/20/99 (HiNI), and B/Shanghai/361/02.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261717

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  9 in total

1.  Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians.

Authors:  Cees C van den Wijngaard; Liselotte van Asten; Adam Meijer; Wilfrid van Pelt; Nico J D Nagelkerke; Gé A Donker; Marianne A B van der Sande; Marion P G Koopmans
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308

2.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

3.  Emergence of avian influenza viruses with enhanced transcription activity by a single amino acid substitution in the nucleoprotein during replication in chicken brains.

Authors:  Tatsuya Tada; Koutaro Suzuki; Yu Sakurai; Masanori Kubo; Hironao Okada; Toshihiro Itoh; Kenji Tsukamoto
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital.

Authors:  A M v d Hoeven; M Scholing; P C Wever; R Fijnheer; M Hermans; P M Schneeberger
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

5.  Internet-based monitoring of influenza-like illness (ILI) in the general population of the Netherlands during the 2003-2004 influenza season.

Authors:  Richard L Marquet; Aad I M Bartelds; Sander P van Noort; Carl E Koppeschaar; John Paget; François G Schellevis; Jouke van der Zee
Journal:  BMC Public Health       Date:  2006-10-04       Impact factor: 3.295

6.  Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection.

Authors:  Judith M Fonville; Pieter L A Fraaij; Gerrie de Mutsert; Samuel H Wilks; Ruud van Beek; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2015-07-03       Impact factor: 5.226

7.  Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.

Authors:  Maryam Darvishian; Frederika Dijkstra; Eva van Doorn; Maarten J Bijlsma; Gé A Donker; Marit M A de Lange; Laura M Cadenau; Eelko Hak; Adam Meijer
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

8.  Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.

Authors:  Eva van Doorn; Maryam Darvishian; Frederika Dijkstra; Gé A Donker; Pieter Overduin; Adam Meijer; Eelko Hak
Journal:  Vaccine       Date:  2017-04-12       Impact factor: 3.641

9.  Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial.

Authors:  Angelique G S C Jansen; Elisabeth A M Sanders; Arno W Hoes; Anton M van Loon; Eelko Hak
Journal:  J Pediatr       Date:  2008-07-14       Impact factor: 4.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.